Vonorasome fumarate tablet is a new acid inhibitor originally developed by Takeda Pharmaceutical, which is used to treat acid related diseases, including reflux Esophagitis (RE), gastric ulcer, duodenal ulcer, prevention of recurrence of gastric ulcer or duodenal ulcer and eradication of Helicobacter pylori during the treatment period with low-dose aspirin or non steroidal anti-inflammatory drugs.